Details for New Drug Application (NDA): 209097
✉ Email this page to a colleague
The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for 209097
Tradename: | METHYLPREDNISOLONE |
Applicant: | Chartwell Rx |
Ingredient: | methylprednisolone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 209097
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Feb 22, 2019 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
Approval Date: | Feb 22, 2019 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 8MG | ||||
Approval Date: | Feb 22, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription